保留晶体前囊的晶体玻璃体切除手术的临床观察

目的评估白内障合并玻璃体病变的联合手术治疗效果。方法对２０只眼白内障合并玻璃体混浊或炎症或异物病变,采用经平坦部保留晶体前囊晶体玻璃体切除手术治疗。术中１６只眼一期植入睫状沟部位人工晶体。结果经１２～３６个月随访,２０只眼中１８只眼视力得到提高,其中０．３～０．５者７只眼,０．５以上者１１只眼,最高者为１．２。１９只眼前囊保持透明,１只眼术后６个月发生混浊。结论该术式保留晶体前囊利于植入人工晶体,手术对眼前段组织损伤轻,术后晶体囊混浊发生率低,是治疗白内障合并玻璃体病变的一种较理想的手术。

Clinical observation on pars plana lensectomy-vitrectomy preserving lens anterior capsule

OBJECTIVE: To investigate the therapeutic effect of combined operation on cataract complicated with vitreous pathology. METHOD: 19 patients (20 eyes) with coexisting cataract and vitreous opacification or endophthalmitis or intraocular foreign bodies were operated with pars plana lensectomy-vitrectomy preserving lens anterior capsule. The ciliary sulcus intraocular lenses (IOLs) were primarily implanted for sixteen eyes of 19 cases in the operation. RESULTS: All cases were followed up for 12-36 months. Visual acuities of 18 cases were improved, 7 eyes between 0.3-0.5, 11 eyes beyond 0.5, the best one at 1.2. Anterior capsule opacification occurred merely in one eye, and in others the capsule kept being transparent. CONCLUSION: Preserving anterior lens capsule in the operation is beneficial to the insertion of IOL, and the anterior segment is affected slightly, thus it is a promising method for treating cataract complicated with vitreous opacification.